Skip to main content
. Author manuscript; available in PMC: 2024 Mar 21.
Published in final edited form as: Travel Med Infect Dis. 2017 May 6;17:50–55. doi: 10.1016/j.tmaid.2017.05.003

Table 4.

Alternate antimalarial use and reasons for switching.

Alternate Antimalarial (N = 965) n(%)
 Mefloquine 98 (10.2)
 Chloroquine 19 (2.0)
 Doxycycline 608 (63.0)
 Atovaquone-proguanil 173 (17.9)
 Other 67 (6.9)
Reason for switching (N = 964)
 Side effects 762 (79.1)
 Deployment to a different area 27 (2.8)
 Other 175 (18.2)